Kanoncure, Inc.

Tottori University

National University Corporation Tottori University

Yohei Kouno

Goshi Shiota

Noriko Itaba

Minoru Morimoto

Kenichiro Abe

Hiroyuki Oka

Hiroki Shimizu

Kenzo Seto

Tomohiko Sakabe

Keita Kanki

Shinya Kunita

Zyunya Adumi

Satoshi Yokogi

A novel therapeutic drug for malignant tumors, cancer stem cells, or fibrosis is obtained. A therapeutic drug for malignant tumors or cancer stem cells is used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof. Alternatively, a therapeutic drug for fibrosis can be used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof.

Inhibitory effect of low molecular weight compound on cancer and fibrosis

To obtain a novel therapeutic drug for a malignant tumor or fibrosis. Used is a compound represented by formula (1), a salt thereof, or a solvate thereof. Also used is a therapeutic drug for a malignant tumor or a therapeutic drug for fibrosis, comprising a compound represented by formula (1), a salt thereof, or a solvate thereof.

Suppression and regeneration promoting effect of low molecular weight compound on cancer and fibrosis

Growing community of inventors

Yonago, Japan

Yohei Kouno